Best Peptides for Growth Hormone
Secretagogues, GHRH analogs, and IGF-1 modulators studied for growth hormone optimization
Growth hormone (GH) peptides are among the most popular research peptides. They work by stimulating the body's own GH production through different mechanisms — either mimicking growth hormone-releasing hormone (GHRH) or activating ghrelin receptors (GH secretagogues/GHRPs).
Unlike exogenous HGH, these peptides aim to work with the body's natural pulsatile GH release pattern. The key differentiators are potency, selectivity, side effect profiles, and whether they raise cortisol or prolactin alongside GH.
Growth Hormone Peptides (10)
MK-677 (Ibutamoren)
MK-677 (Ibutamoren) is an oral (non-injectable) compound that triggers growth hormone release by mimicking the hunger hormone ghrelin. Research focuses on increasing growth hormone and IGF-1 levels, improving sleep quality, body composition, and bone density.
CJC-1295 (Modified GRF 1-29)
CJC-1295 without DAC (also called Modified GRF 1-29) is a synthetic growth hormone-releasing compound with a short active window of about 30 minutes. It is being studied for its effects on growth hormone release and body composition.
CJC-1295 with DAC
CJC-1295 with DAC (Drug Affinity Complex) is a long-acting growth hormone-releasing compound that binds to a blood protein called albumin, extending its active life to several days. This provides sustained growth hormone elevation compared to the shorter-acting Mod GRF 1-29.
Sermorelin
Sermorelin is a synthetic 29-amino-acid growth hormone-releasing compound. It was FDA-approved for pediatric growth hormone deficiency and is widely used off-label for anti-aging and body composition improvement.
Tesamorelin
Tesamorelin is a synthetic growth hormone-releasing compound used for reducing deep abdominal fat in patients with lipodystrophy (abnormal fat distribution). It is FDA-approved and marketed as Egrifta, specifically targeting visceral fat accumulation.
IGF-1 LR3
IGF-1 LR3 is a modified version of insulin-like growth factor 1 with structural changes that reduce its binding to carrier proteins. These modifications increase its potency and extend how long it stays active in the body compared to natural IGF-1.
Ipamorelin
Ipamorelin is a selective compound that triggers growth hormone release, originally developed by Novo Nordisk. It stimulates growth hormone without significantly affecting cortisol or prolactin levels. It has been studied in clinical trials for postoperative recovery.
GHRP-6
GHRP-6 (Growth Hormone Releasing Peptide-6) is a six-amino-acid peptide that triggers growth hormone release through the ghrelin (hunger hormone) receptor. It is known for strong growth hormone release but also significant appetite stimulation.
Hexarelin
Hexarelin is a synthetic six-amino-acid peptide and one of the most potent compounds that trigger growth hormone release. Beyond its growth hormone effects, research also shows heart-protective properties that work independently of growth hormone.
GHRP-2
GHRP-2 (Growth Hormone Releasing Peptide-2) is a synthetic six-amino-acid peptide that triggers growth hormone release. It is considered more potent than GHRP-6 with less appetite stimulation.
Frequently Asked Questions
What is the best growth hormone peptide for beginners?
Ipamorelin is often considered the most beginner-friendly GH peptide because it selectively stimulates GH release without significantly raising cortisol, prolactin, or ghrelin. It has a clean side effect profile compared to GHRP-6 or Hexarelin.
What is the difference between CJC-1295 and Ipamorelin?
CJC-1295 is a GHRH analog (stimulates GH release from the pituitary via the GHRH receptor), while Ipamorelin is a GHRP (stimulates GH via the ghrelin receptor). They work through different pathways and are often used together for a synergistic effect on GH output.
Is MK-677 a peptide?
MK-677 (Ibutamoren) is technically not a peptide — it's a non-peptide ghrelin receptor agonist. However, it's commonly discussed alongside GH peptides because it serves the same function: stimulating growth hormone secretion. Its key advantage is oral bioavailability.